Christopher Schelling
Director/Board Member chez Cascade Prodrug, Inc.
Profil
Christopher Schelling is the founder of Censa Pharmaceuticals, Inc. (founded in 2015), Acer Therapeutics, Inc. (founded in 2017), and Apanii Consulting LLC (founded in 2012).
He held the titles of Secretary, Director & Head-Operations at Censa Pharmaceuticals, Inc. and President, Chief Executive Officer & Director at Acer Therapeutics, Inc. Mr. Schelling's current job is Director at Cascade Prodrug, Inc. where he started in 2017.
Mr. Schelling's former jobs include President, Chief Executive Officer & Director at Opexa Therapeutics, Inc. and Executive Director-Strategic Marketing at BioMarin Pharmaceutical, Inc. where he worked from 2006 to 2012.
Mr. Schelling received his undergraduate degree from Carroll College (Montana).
Mr. Schelling is also the founder of Acer Therapeutics, Inc.
Postes actifs de Christopher Schelling
Sociétés | Poste | Début |
---|---|---|
Cascade Prodrug, Inc.
Cascade Prodrug, Inc. Pharmaceuticals: MajorHealth Technology Cascade Prodrug, Inc. engages is the research and development of targeted prodrug therapies. It provides technology for the treatment of hyper-proliferative diseases. The company was founded by August J. Sick and Allan Cochrane and is headquartered in Eugene, OR. | Director/Board Member | 01/06/2017 |
Anciens postes connus de Christopher Schelling
Sociétés | Poste | Fin |
---|---|---|
ACER THERAPEUTICS INC. | Founder | 17/11/2023 |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Founder | 01/05/2020 |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/10/2012 |
Apanii Consulting LLC
Apanii Consulting LLC Miscellaneous Commercial ServicesCommercial Services Apanii Consulting LLC provides pharmaceutical and biotechnology consulting services. The private company is based in Bend, OR. The company was founded by Christopher Schelling. | Chief Executive Officer | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Chief Executive Officer | - |
Formation de Christopher Schelling
Carroll College (Montana) | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Cascade Prodrug, Inc.
Cascade Prodrug, Inc. Pharmaceuticals: MajorHealth Technology Cascade Prodrug, Inc. engages is the research and development of targeted prodrug therapies. It provides technology for the treatment of hyper-proliferative diseases. The company was founded by August J. Sick and Allan Cochrane and is headquartered in Eugene, OR. | Health Technology |
Acer Therapeutics, Inc. /Old/
Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. develops therapeutics for the treatment of orphan diseases. Its current pipeline consists of two late-stage clinical products: ACER-002 for vascular Ehlers-Danlos Syndrome (vEDS), and ACER-001 for Maple Syrup Urine Disease (MSUD). The company was founded by Chris Schelling and is headquartered in Cambridge, MA. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
Apanii Consulting LLC
Apanii Consulting LLC Miscellaneous Commercial ServicesCommercial Services Apanii Consulting LLC provides pharmaceutical and biotechnology consulting services. The private company is based in Bend, OR. The company was founded by Christopher Schelling. | Commercial Services |